IL53013A0 - 1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing them - Google Patents
1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing themInfo
- Publication number
- IL53013A0 IL53013A0 IL53013A IL5301377A IL53013A0 IL 53013 A0 IL53013 A0 IL 53013A0 IL 53013 A IL53013 A IL 53013A IL 5301377 A IL5301377 A IL 5301377A IL 53013 A0 IL53013 A0 IL 53013A0
- Authority
- IL
- Israel
- Prior art keywords
- heterocyclyloxypropane
- hydroxy
- derivatives
- amino
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1263576A CH607585A5 (en) | 1976-10-05 | 1976-10-05 | Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine |
Publications (2)
Publication Number | Publication Date |
---|---|
IL53013A0 true IL53013A0 (en) | 1977-11-30 |
IL53013A IL53013A (en) | 1981-09-13 |
Family
ID=4384944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL53013A IL53013A (en) | 1976-10-05 | 1977-09-28 | 1-phehethylamino-2-hydroxy-3-pyridyloxy-(or pyrazinyloxy) propanes,their production and pharmaceutical compositions containing them |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPS5350177A (en) |
AT (1) | AT358037B (en) |
AU (1) | AU514676B2 (en) |
BE (1) | BE858867A (en) |
CA (1) | CA1105021A (en) |
CH (1) | CH607585A5 (en) |
DE (1) | DE2740678A1 (en) |
DK (1) | DK402877A (en) |
ES (1) | ES462389A1 (en) |
FI (1) | FI772681A (en) |
FR (1) | FR2367065A1 (en) |
GB (1) | GB1591723A (en) |
GR (1) | GR71677B (en) |
IE (1) | IE45692B1 (en) |
IL (1) | IL53013A (en) |
NL (1) | NL7710394A (en) |
NO (1) | NO773125L (en) |
NZ (1) | NZ185267A (en) |
PT (1) | PT67048B (en) |
SE (1) | SE7710250L (en) |
ZA (1) | ZA775698B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4210653A (en) * | 1978-06-27 | 1980-07-01 | Merck & Co., Inc. | Pyridyloxypropanolamines |
DK267779A (en) * | 1978-06-27 | 1979-12-28 | Merck & Co Inc | PROCEDURE FOR THE PREPARATION OF N-ARALKYLAMINO-PROPOXYCYANOPYRIDINES |
US4208416A (en) * | 1978-06-27 | 1980-06-17 | Merck & Co., Inc. | N-Aralkyl containing cyanopyridines |
GB8510146D0 (en) * | 1985-04-20 | 1985-05-30 | Smith Kline French Lab | Chemical compounds & processes |
ES2038180T3 (en) * | 1986-06-30 | 1993-07-16 | Asahi Kasei Kogyo Kabushiki Kaisha | A PROCEDURE FOR PREPARING A COMPOUND THAT IS A DERIVATIVE OF PIRAZINE. |
WO2001036412A1 (en) * | 1999-11-15 | 2001-05-25 | Eli Lilly And Company | Process for the preparation of aryloxy propanolamines |
-
1976
- 1976-10-05 CH CH1263576A patent/CH607585A5/en not_active IP Right Cessation
-
1977
- 1977-09-09 DK DK402877A patent/DK402877A/en unknown
- 1977-09-09 AT AT648777A patent/AT358037B/en not_active IP Right Cessation
- 1977-09-09 DE DE19772740678 patent/DE2740678A1/en not_active Withdrawn
- 1977-09-09 NO NO773125A patent/NO773125L/en unknown
- 1977-09-12 FI FI772681A patent/FI772681A/en not_active Application Discontinuation
- 1977-09-13 SE SE7710250A patent/SE7710250L/en not_active Application Discontinuation
- 1977-09-15 ES ES462389A patent/ES462389A1/en not_active Expired
- 1977-09-16 FR FR7728037A patent/FR2367065A1/en active Granted
- 1977-09-19 JP JP11169877A patent/JPS5350177A/en active Pending
- 1977-09-19 PT PT67048A patent/PT67048B/en unknown
- 1977-09-20 GB GB39204/77A patent/GB1591723A/en not_active Expired
- 1977-09-20 BE BE181044A patent/BE858867A/en not_active IP Right Cessation
- 1977-09-22 NL NL7710394A patent/NL7710394A/en not_active Application Discontinuation
- 1977-09-22 IE IE1938/77A patent/IE45692B1/en unknown
- 1977-09-23 ZA ZA00775698A patent/ZA775698B/en unknown
- 1977-09-23 CA CA287,391A patent/CA1105021A/en not_active Expired
- 1977-09-26 NZ NZ185267A patent/NZ185267A/en unknown
- 1977-09-26 AU AU29125/77A patent/AU514676B2/en not_active Expired
- 1977-09-28 IL IL53013A patent/IL53013A/en unknown
- 1977-09-29 GR GR54455A patent/GR71677B/el unknown
Also Published As
Publication number | Publication date |
---|---|
FR2367065A1 (en) | 1978-05-05 |
AU514676B2 (en) | 1981-02-19 |
NO773125L (en) | 1978-04-06 |
PT67048A (en) | 1977-10-01 |
DK402877A (en) | 1978-04-06 |
FR2367065B1 (en) | 1980-10-10 |
GR71677B (en) | 1983-06-21 |
ATA648777A (en) | 1980-01-15 |
CH607585A5 (en) | 1978-09-15 |
ES462389A1 (en) | 1978-07-01 |
IE45692B1 (en) | 1982-10-20 |
BE858867A (en) | 1978-03-20 |
JPS5350177A (en) | 1978-05-08 |
DE2740678A1 (en) | 1978-04-06 |
SE7710250L (en) | 1978-04-06 |
PT67048B (en) | 1979-02-16 |
FI772681A (en) | 1978-04-06 |
GB1591723A (en) | 1981-06-24 |
AT358037B (en) | 1980-08-11 |
IE45692L (en) | 1978-04-05 |
ZA775698B (en) | 1978-05-30 |
CA1105021A (en) | 1981-07-14 |
IL53013A (en) | 1981-09-13 |
NZ185267A (en) | 1979-07-11 |
AU2912577A (en) | 1979-04-05 |
NL7710394A (en) | 1978-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL53533A0 (en) | Novel tetralin derivatives their production and pharmaceutical compositions containing them | |
IL51840A0 (en) | Trans-hexahydro-pyrido-indoles their production and pharmaceutical compositions containing them | |
IL52858A0 (en) | New derivatives of perhydro-aza-heterocycles their production and pharmaceutical compositions containing them | |
IL52337A0 (en) | Novel dipeptide derivatives their manufacture and pharmaceutical compositions containing them | |
IL52493A0 (en) | 5-aroyl-pyrrolopyrrole-1-carboxylic acid derivatives their production and pharmaceutical compositions containing them | |
IL51966A0 (en) | Novel aminopiperidines their production and pharmaceutical compositions incorporating them | |
IL51360A0 (en) | New polypeptide derivatives their production and pharmaceutical compositions containing them | |
IL52517A0 (en) | New isoxazole derivatives their production and pharmaceutical compositions containing them | |
IL51812A0 (en) | New isothiazolopyridine derivatives their preparation and pharmaceutical compositions containing them | |
IL52307A0 (en) | Novel dipeptide derivatives their manufacture and pharmaceutical compositions containing them | |
IL53332A0 (en) | Morphanthridine derivatives their production and pharmaceutical compositions containing them | |
IL51334A0 (en) | Novel pyrrolidine derivatives their production and pharmaceutical compositions containing them | |
IL51426A0 (en) | Novel derivatives of tetrahydroechinocandin b their production and pharmaceutical compositions containing them | |
GB2032423B (en) | N - phenyl-indoline derivatives their production and pharmaceutical compositions containing them | |
IL51456A0 (en) | New piperazine derivatives their production and pharmaceutical compositions containing them | |
IL54105A (en) | 2-acylamino-4-amino-5-benzylpyrimidine derivatives,their production and pharmaceutical compositions containing them | |
IL53013A0 (en) | 1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing them | |
IL53642A0 (en) | New indoloquinolizine derivatives their preparation and pharmaceutical compositions containing them | |
IL52006A0 (en) | Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them | |
IL53009A0 (en) | New imidazoisoquinoline derivatives their preparation and pharmaceutical compositions containing them | |
JPS5394028A (en) | Pharmaceutical composition and production thereof | |
IL51194A0 (en) | Novel ergoline derivatives their production and pharmaceutical compositions containing them | |
IL53120A0 (en) | Novel quinoline derivatives their production and pharmaceutical compositions containing them | |
IL50198A0 (en) | New morphanthridine derivatives their production and pharmaceutical compositions containing them | |
IL52962A0 (en) | New perhydroindolinol derivatives their preparation and pharmaceutical compositions containing them |